Neoplasia/BPH

	Applying the Caring Life-Course Theory to Explore Prostate Cancer Survivors' Care Needs, Care Trajectories, And Self-Care Behaviors: A Qualitative Study. Semin Oncol Nurs Lawless MT, Pinero de Plaza MA, Thamm C, Kitson A, Paterson C. PMID: 40962639 [PubMed - as supplied by publisher]
	Reply to NatÃ¡lia Dalsenter Avilez, TomÃ¡s Bernardo Costa Moretti, and Leonardo Oliveira Reis' Letter to the Editor re: Anna Lantz, Ying Li, Stefan Carlsson, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.004. Eur Urol Oncol Lantz A, Li Y, Carlsson S, Stranne J, Angenete E, Akre O, Bjartell A, Mansoori M, Ehrencrona C, Wiklund P, Haglind E. PMID: 40962576 [PubMed - as supplied by publisher]
	Re: Anna Lantz, Ying Li, Stefan Carlsson, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.004. Eur Urol Oncol Avilez ND, Moretti TBC, Reis LO. PMID: 40962575 [PubMed - as supplied by publisher]
	Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma. Clin Genitourin Cancer Goodstein T, Goradia R, Srivastava A, Sood A, Dason S, Master VA, Singer EA. PMID: 40962570 [PubMed - as supplied by publisher]
	Germline whole-exome sequencing reveals FOXP3-related gene variants conferring urinary cancer susceptibility and associated with immune escape. J Immunother Cancer Feng BJ, Kohlmann W, Nix DA, Atkinson A, Boucher KM, Carroll C, Stubben CJ, Kolesar J, Singer EA, Riedlinger G, Edge S, Sahu KK, Churchman M, Graham L, Salhia B, Sanchez A, Zakharia Y, Schneider BP, Jain R, Byrne L, Moskaluk CA, Nepple K, Shabsigh A, Chahoud J, Cairns BR, Gupta S. PMID: 40962358 [PubMed - indexed for MEDLINE]
	Socioeconomic Disparities in Prostate Cancer Presentation: The Impact of ADI on Prostate Cancer Stage at Diagnosis. Clin Genitourin Cancer Bertini A, Tylecki A, Stephens A, Finocchiaro A, Viganò S, Cusmano N, Dinesh A, Guivatchian E, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. PMID: 40961906 [PubMed - as supplied by publisher]
	Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial. JCO Precis Oncol Weiner AB, Proudfoot JA, Aker M, Cardenas M, Gonzalez S, Kelly E, Davicioni E, Sisk AE Jr, Brisbane WG, Marks LS. PMID: 40961406 [PubMed - indexed for MEDLINE]
	Optimized Biopsy Strategy for Transition Zone Prostate Cancer With Enhanced Perilesional Sampling: A Retrospective Analysis and Clinical Trial Validation. JCO Precis Oncol Chen X, Huang C, Zhou C, Li Y, Huang R, Bao J, Lin Y, Truß MC, Hou J, Huang Y, Wei X. PMID: 40961404 [PubMed - indexed for MEDLINE]
	Characterizing pelvic organ descent in women after radical cystectomy: an exploratory analysis. World J Urol Williams C, Talwar R, Ramchandani P, Smith AL. PMID: 40960606 [PubMed - indexed for MEDLINE]
	Nomogram for Predicting Postoperative Blood Pressure Reduction in Hypertensive Patients: A Single-Center Retrospective Study. Int J Med Sci Zhang Z, Ma X, Li Z, Wei H, Jia K, Xu C, Zhu S, Wen S, Quan C. PMID: 40959573 [PubMed - indexed for MEDLINE]
	FAM174B remodels the tumor microenvironment, inhibits the infiltration of macrophage, predicts the molecular subtype and therapeutic response of bladder cancer. Int J Med Sci Chen H, Ma L, Ji Z, Dong J. PMID: 40959568 [PubMed - indexed for MEDLINE]
	Uncommon Manifestations of Newly Diagnosed B-cell Chronic Lymphocytic Leukemia Prompting the Concurrent Diagnosis of Advanced Prostate Cancer: A Case Report. Cureus Stafylidis C, Patsialos I, Stefanou D, Lakiotaki E, Diamantopoulos P. PMID: 40959367 [PubMed]
	SETD2 and EZH2: Two epigenetic drivers of prostate cancer. J Cancer Wang J, Xiang L, Zhang H, Zhang X. PMID: 40959108 [PubMed]
	Dynamic changes of urinary microbiota in patients with bladder cancer after surgery and its clinical significance. Front Immunol Lang Y, Li P, He R, Zhu B, Wang G, Li J. PMID: 40959077 [PubMed - indexed for MEDLINE]
	Potential application of nanodelivery systems targeting ELAVL1 in prostate cancer treatment. Front Oncol Min S, Guo M, Du J, Chen J, Shen Y, Yuan F, Wang Z, Cai Z. PMID: 40958880 [PubMed]
	Impact of physiotherapy interventions in urinary incontinence and on overall quality of life in patients undergoing treatment for prostate cancer: A systematic review. Urologia Agarwal P, Chahal A, Sharma N, Rai RH, Urazbaeva Y, Djumaniyazova M, Sharma A. PMID: 40958699 [PubMed - as supplied by publisher]
	The mediating effect of dyadic coping between illness perception and fear of disease progression in bladder cancer patients: A cross-sectional survey. Medicine (Baltimore) Liu Y, Li J, Liang G, Fang F, Wang S. PMID: 40958288 [PubMed - indexed for MEDLINE]
	Causal relationships between immune cells and common urinary system tumors: A bidirectional analysis of Mendelian randomization. Medicine (Baltimore) Liu Z, Tu J, Long J, Guo L. PMID: 40958287 [PubMed - indexed for MEDLINE]
	Immune-related hepatic adverse events in renal cell carcinoma patients treated with immune checkpoint inhibitors: a retrospective study. BJC Rep Saleh A, Grünwald V, Hilser T, Darr C. PMID: 40957947 [PubMed]
	Practical tricks and recommendations on BRCA1/2 testing in prostate cancer: from therapy to cancer prevention. Crit Rev Oncol Hematol Tibiletti MG, Carnevali I, Cimadamore A, Oliani C, Lapini A, Genuardi M, Bracarda S, Rescigno P, AIFET and SIURO. PMID: 40957532 [PubMed - as supplied by publisher]

Articles 1 - 20 / 179518

Page 1 of 8976



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy